Retraction: Evaluation of periimplant bone neoformation using different scanning electron microscope methods for measuring BIC. A dog study.

In relation to the article of the Journal of Clinical and Experimental Dentistry "Calvo-Guirado JL, Aguilar-Salvatierra A, Guardia J, Delgado-Ruiz R, Ramírez-Fernández MP, Pérez-Sánchez C, Gómez-Moreno G. Evaluation of periimplant bone neoformation using different scanning electron microscope methods for measuring BIC. A dog study. J Clin Exp Dent. 2012 Feb 1;4(1):e8-e13", the authors have used three figures that are the same as those published in three different publications (J Pineal Res 2010; COIR 2010; COIR 2012). The copyright of the mentioned publications was consequently not respected. Retraction of the article is therefore decided.

Effect of inhaled corticosteroids on salival composition: a cross-sectional study in patients with bronchial asthma.

BACKGROUND: To date, no evidence exists in the literature as to the effects of inhaled corticosteroids (ICs) on salivary composition in patients with bronchial asthma. OBJECTIVE: The aim of this study was to assess the effect of ICs on salival composition. METHODS: Adult patients attending an outpatient respiratory clinic who were classified into two groups (controls and patients with bronchial asthma receiving ICs), were recruited in this cross-sectional study. For each participant, data of clinical records, baseline history of asthma, and regular IC dose were recorded. A sample of stimulated saliva was collected and processed for investigation of mucin 5B (MUC5B), lipoxygenase (LPO), total antioxidant capacity, and 8-hydroxydeoxyguanosine (8-OHdG) levels. RESULTS: Overall, 103 patients (49 controls and 54 patients receiving regular treatment with ICs) were recruited. No differences in comorbidities or smoking habits were observed. Patients treated with high-doses of ICs showed lower levels of salival MUC5B compared with those treated with medium IC doses or those not treated with ICs (1.60 vs. 2.20 vs. 2.53 ng/mL; p = 0.042). CONCLUSION: In patients with asthma, treatment with high-doses of ICs is associated with reduced levels of salivary MUC5B. This effect can explain some of the effects of ICs on oral health.

Outcomes of topical applications of melatonin in implant dentistry: a systematic review.

BACKGROUND: Due to its antioxidant properties and its ability to detoxify free radicals, melatonin may interfere in the function of osteoclasts and thereby inhibit bone resorption. This inhibition of bone resorption may be enhanced by a reaction of indolamine in osteoclastogenesis and this may contribute to certain benefits in implantology. OBJECTIVE: This systematic literature review on the use of melatonin in implant dentistry aims to provide guidelines for clinicians. MATERIALS AND METHODS: PubMed, Science Direct, ISI Web of Knowledge, and the Cochrane base databases were used to identify articles published between 1999 and 2013 on melatonin use in implant dentistry. Ten articles were selected consisting of 9 animal research studies and 1 review article, involving 60 Beagle dogs, 57 rats, and 30 rabbits and a total of 352 implants. RESULTS: Melatonin, which is released into the saliva, has important implications in the oral cavity. To achieve dental implant stability, osseointegration involves a cascade of protein and cell apposition, vascular invasion, bone formation, and maturation. This process may be accelerated by local delivery of growth-promoting factors, as occurs with the topical application of melatonin over the implant surface. CONCLUSIONS: The experimental evidence suggests that topical applications of melatonin may be useful in oral surgery and implant dentistry, increasing bone-to-implant contact values and new bone formation, and so improving the success and long-term survival of implant treatments.

Xerostomia relates to the degree of asthma control.

Few studies have assessed the relationships between xerostomia and the use of inhaled corticosteroids (ICS). The main objective of this study was to investigate the prevalence of xerostomia in a respiratory outpatient clinic and its relationship with bronchial asthma and ICS use. A cross-sectional observational study of patients recruited in an outpatient setting divided them according to previous diagnoses of bronchial asthma. Data about pulmonary function, concomitant medication, medical comorbidities, Xerostomia Inventory test (XI test), and the degree of asthma control by ACT (asthma control test) were collected for each patient. A linear regression model was applied, using the XI score as dependent variable and the ACT score as independent variable. The 57 patients were divided into asthmatics (40 patients, 70.2%) and control group without asthma (17, 29.8%). The prevalence of xerostomia was 87.7% (50 patients), with no differences between the study groups or current dose of ICS. In the asthmatic group, patients with uncontrolled asthma had worse XI scores than those with partially or totally controlled asthma (30.43 ± 8.71 vs. 24.92 ± 8.08; P < 0.05). In a logistic regression model, the XI test was significantly associated to ACT scores with a moderately strong correlation (r = 0.55; P = 0.005) after adjusting for the current daily dose of ICS. Xerostomia is a common symptom in the ambulatory setting. There is a moderate relationship between the degree of asthma control and the severity of xerostomia.

Peri-implant evaluation in type 2 diabetes mellitus patients: a 3-year study.

OBJECTIVE: The aim of this study was to analyze the changes produced in peri-implant tissues in type 2 diabetes mellitus patients with different glycemia levels, measured by monitoring glycated hemoglobin A1c (HbA1c), over a period of 3 years following dental implant placement. MATERIALS AND METHODS: Sixty-seven patients were divided into four groups according to their HbA1c levels: 21 patients in Group 1 (<6); 24 patients in Group 2 (6.1-8); and 11 patients in Group 3 (8.1-10) and Group 4 (>10.1). Each patient received one implant. All implants were placed in the anterior zone of the maxilla. The variables selected to assess the general state of patients' peri-implant health were as follows: probing depth, bleeding on probing, and marginal bone loss. RESULTS: Marginal bone loss was found to increase in relation to increases in HbA1c levels. Bleeding on probing showed statistically significant differences between groups. When the peri-implant area was probed, mean levels of bleeding varied from 0.43 in Group 1 at 1 year after implant surgery to 0.62 in Group 4 (P = 0.042 between the four study groups). After the second year, greater bleeding on probing was observed in Group 4 (0.63) in comparison with groups with lower HbA1c levels. Peri-implant pocket depths presented values that were too low to be considered pathological and without statistically significant differences between the study groups. CONCLUSION: Implant therapies for diabetic patients can be predictable, providing these patients fall within controlled ranges of glycemia over time, assessed by monitoring HbA1c levels.

Marginal bone loss evaluation around immediate non-occlusal microthreaded implants placed in fresh extraction sockets in the maxilla: a 3-year study.

OBJECTIVE: To evaluate marginal bone loss over 3 years around immediate microthreaded implants placed in the maxillary anterior/esthetic zone and immediately restored with single crowns. MATERIAL AND METHODS: Seventy-one implants (with microthreads up to the platform--rough surface body and neck, internal connection and platform switching) were placed in fresh extraction sockets in the maxillary arches of 30 men and 23 women (mean age 37.85 ± 7.09 years, range 27-60). All subjects had at least 3 mm of soft tissue to allow the establishment of adequate biologic width and to reduce bone resorption. Each patient received a provisional restoration immediately after implant placement with slight occlusal contact. Mesial and distal bone height was evaluated using digital radiography on the day following implant placement (baseline) and after 1, 2, and 3 years. Primary stability was measured with resonance frequency analysis. RESULTS: No implants failed, resulting in a cumulative survival rate of 100% after 3 years. Marginal bone loss from implant collar to bone crest measured at baseline (peri-implant bone defect at the fresh extraction socket) and after 3 years was 0.86 mm ± 0.29 mm. Mesial and distal site crestal bone loss ranged from 3.42 mm ± 1.2 mm at baseline to 3.51 mm ± 1.5 mm after 3 years (P = 0.063) and from 3.38 mm ± 0.9 mm at baseline to 3.49 mm ± 0.9 mm after 3 years, respectively (P = 0.086). CONCLUSIONS: This prospective study found minimal marginal bone loss and a 100% implant survival rate over the 3-year follow-up for microthreaded immediate implants subjected to immediate non-occlusal loading.

Histological, radiological and histomorphometric evaluation of immediate vs. non-immediate loading of a zirconia implant with surface treatment in a dog model.

OBJECTIVE: The aim of this study was to assess the performance of zirconia implants under immediate loading compared with delayed loading in dogs over 30-90 days. MATERIALS AND METHODS: Tooth extractions were made for the subsequent placement of dental implants at premolars P2, P3, P4 and molars M1 bilaterally in the dog mandible. Forty eight zirconia implants, 4 mm in diameter and 10 mm in length, were inserted, whose neck and body surfaces had been treated with femtosecond laser texturing; 24 implants were loaded immediately and 24 remained unloaded during the osseointegration period. Final radiographs were taken recording stability values before sacrifice at 30 or 90 days when sample removal for histological and histomorphometric analysis was performed. Bone-to-implant contact, crestal bone loss and implant stability were evaluated at these two study times. RESULTS: Bone-to-implant contact values after 30 days were 38.9% for immediately loaded implants and 32% for non-loaded implants. After 90 days, values increased to 65% for immediately loaded and 57.6% for non-loaded implants. After 30 days, there was more crestal bone lost in the non-loaded group (0.58 ± 0.28 mm) compared with the immediately loaded group (0.5 ± 0.3 mm). After 90 days, there was improved stability in both groups, but was lower in the immediately loaded group (0.5 ± 0.23 mm) compared with the non-loaded group (0.56 ± 0.28 mm). Initial implant stability values were -3.5 PTV at the moment of implant placement. Stability values after the first 30 days were -4 for immediately loaded implants and -3 for non-loaded. At 90 days, non-loaded implants showed -4.9, whereas immediately loaded showed -7.1. CONCLUSIONS: For the different parameters studied, zirconia implants treated with femtosecond laser and subjected to immediate loading showed better results compared with non-loaded implants in terms of BIC, crestal bone loss and implant stability.

Evaluation of the efficacy of a topical sialogogue spray containing malic acid 1% in elderly people with xerostomia: a double-blind, randomized clinical trial.

OBJECTIVE: The aim of this study was to evaluate the clinical efficacy of a topical sialogogue spray containing 1% malic acid for elderly people affected by xerostomia. MATERIAL AND METHODS: This research took the form of a double-blind, randomized clinical trial. Forty-one individuals (mean age: 78.7 years) with xerostomia were divided into two groups: for the first 'intervention group' (21 subjects) a topical sialogogue spray (1% malic acid) was applied, while for the second 'control group' (20 subjects), a placebo spray was applied; for both groups, the sprays were applied on demand during 2 weeks. The Xerostomia Inventory (XI) was used to evaluate xerostomia levels before and after product/placebo application. Unstimulated and stimulated salivary flows rates, before and after spray application, were measured. RESULTS: XI scores decreased significantly (clinically meaningful) from 36.4 ± 7.3 points to 29.1 ± 7.1 (p < 0.05) with an XI difference of 7.2 ± 6.1, after the combination among 1% malic acid with xylitol and fluoride application. After 2 weeks of 1% malic acid application, unstimulated and stimulated salivary flows rates increased significantly (p < 0.05). CONCLUSION: A topical sialogogue spray containing 1% malic acid improved xerostomia in an elderly population and increased unstimulated and stimulated salivary flows rates.

Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs.

OBJECTIVES: Assessing the clinical effectiveness of a topical sialogogue on spray (malic acid, 1%) in the treatment of xerostomia induced by antihypertensive drugs. STUDY DESIGN: This research has been carried out through a randomized double-blind clinical trial. 45 patients suffering from hypertensive drugs-induced xerostomia were divided into 2 groups: the first group (25 patients) received a topical sialogogue on spray (malic acid, 1%) whereas the second group (20 patients) received a placebo. Both of them were administered on demand for 2 weeks. Dry Mouth Questionnaire (DMQ) was used in order to evaluate xerostomia levels before and after product/placebo application. Unstimulated and stimulated salivary flows rates, before and after application, were measured. All the statistical analyses were performed by using SPSS software v17.0. Different DMQ scores at the earliest and final stage of the trial were analysed by using Mann-Whitney U test, whereas Student's T-test was used to analyse salivary flows. Critical p-value was established at p<0.05. RESULTS: DMQ scores increased significantly (clinical recovery) from 1.21 to 3.36 points (p<0.05) after malic acid (1%) application whereas DMQ scores increased from 1.18 to 1.34 points (p>0.05) after placebo application. After two weeks of treatment with malic acid, unstimulated salivary flow increased from 0.17 to 0.242 mL/min whereas the stimulated one increased from 0.66 to 0.92 mL/min (p<0.05). After placebo application unstimulated flow ranged from 0.152 to 0.146 mL/min and stimulated flow increased from 0.67 to 0.70 mL/min (p>0.05). CONCLUSIONS: Malic acid 1% spray improved antihypertensive-induced xerostomia and stimulated the production of saliva.

Biomechanical and bone histomorphological evaluation of two surfaces on tapered and cylindrical root form implants: an experimental study in dogs.

PURPOSE: The aim of this study was to evaluate the early bone response of tapered and cylindrical root form implants with two different surface treatments in fresh extraction sockets after 4 and 8 weeks. MATERIALS AND METHODS: Surface treatments and implant design comprised (n = 9 each): tapered with dual acid-etched surface; tapered with dual acid-etched and sandblasted surface (T DAE SB); cylindrical with dual acid-etched surface (C DAE); and cylindrical with dual acid-etched and sandblasted surface (C DAE SB). Implants were placed in the distal sockets of mandibular premolars (2 P2, 3 P3, 4 P4 ) of six beagle dogs, remaining in vivo for 4 and 8 weeks. After sacrifice, the implants were subjected to torque to the point of interface fracture and subsequently nondecalcified for histomorphological study. Statistical analysis was performed by a General Linear Model (GLM) analysis of variance model with a significance level of 5%. RESULTS: Torque to interface fracture was significantly greater for the C DAE SB group than for the other groups (p < .001). Histomorphological analysis showed woven bone formation around all implant surfaces at 4 weeks and its replacement by lamellar bone at 8 weeks. Study time (4 or 8 weeks) did not affect torque measures. CONCLUSIONS: The double acid-etched and sandblasted sample surface increased early bone biomechanical fixation of both cylindrical and tapered root form implants. The cylindrical root form implants showed higher torque to interface fracture values when compared with the tapered root form implants. The C DAE SB surface group showed the highest biomechanical fixation values (p < .001).

Evaluation of primary stability of self-tapping and non-self-tapping dental implants. A 12-week clinical study.

PURPOSE: The aim of this study was to investigate the relationship between surgical techniques and implant macro-design (self-tapping/non-self-tapping) for the optimization of implant stability in the low-density bone present in the posterior maxilla using resonance frequency analysis (RFA). MATERIALS AND METHODS: A total of 102 implants were studied. Fifty-six self-tapping BlueSkyBredent® (Bredent GmbH&Co.Kg®, Senden, Germany) and 56 non-self-tapping Standard Plus Straumann® (Institut Straumann AG®, Waldenburg, Switzerland) were placed in the posterior segment of the maxilla. Implants of both types were placed in sites prepared with either lateral bone-condensing or with bone-drilling techniques. Implant stability measurements were performed using RFA immediately after implant placement and weekly during a 12-week follow-up period. RESULTS: Both types of implants placed after bone condensing achieved significantly higher stability immediately after surgery, as well as during the entire 12-week observation period compared with those placed following bone drilling. After bone condensation, there were no significant differences in primary stability or in implant stability after the first week between both implant types. From 2 to 12 postoperative weeks, significantly higher stability was shown by self-tapping implants. After bone drilling, self-tapping implants achieved significantly higher stability than non-self-tapping implants during the entire follow-up period. CONCLUSIONS: The outcomes of the present study indicate that bone drilling is not an effective technique for improving implant stability and, following this technique, the use of self-tapping implants is highly recommended. Implant stability optimization in the soft bone can be achieved by lateral bone-condensing technique, regardless of implant macro-design.

The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: a double-blind, randomized clinical trial.

BACKGROUND: One of the most important antidepressants side effects is dry mouth. The aim of this study was to evaluate the clinical efficacy of a topical sialogogue spray containing 1% malic acid on patients affected by dry mouth caused by antidepressants drug. MATERIALS AND METHODS: This research took the form of a double-blind, randomized clinical trial at Faculty of Dentistry of University of Granada (Spain). Seventy participants with antidepressant-induced dry mouth were divided into two groups: for the first "intervention group" (35 subjects) a topical sialogogue spray (1% malic acid) was applied, while for the second "control group" (35 subjects), a placebo spray was applied; for both groups, the sprays were applied on demand during 2 weeks. The dry mouth questionnaire (DMQ) was used to evaluate dry mouth symptoms before and after product/placebo application. Unstimulated and stimulated salivary flows rates, before and after application, were measured. RESULTS: Dry mouth symptoms improved after 1% malic acid topical spray application (p < .05). After 2 weeks of 1% malic acid application, unstimulated and stimulated salivary flows rates increased significantly (p < .05). CONCLUSIONS: A sialogogue spray containing 1% malic acid improved dry mouth feeling of the patients suffering antidepressant-induced dry mouth and increased unstimulated and stimulated salivary flows rates.

Biological response to porcine xenograft implants: an experimental study in rabbits.

PURPOSE: The aim of this study was to evaluate the effect of a new porcine biomaterial and collagen paste in 20 New Zealand rabbits. MATERIALS AND METHODS: Forty implants using a porcine xenograft made up of 80% corticocancellous collagenated bone particles of ≤300 µm in size were placed in the proximal metaphyseal area of both tibiae. Four periods of time were formed: 1h, 5, 8, and 15 months. After implantation, an anteroposterior and lateral radiological study was carried out. Samples were sectioned at 5 µm and stained using hematoxylin-eosin, Masson's trichromic, and Gordon-Switt reticulin stains. RESULTS: These results confirmed the biocompatibility of this porcine biomaterial-collagen paste; only a few, occasional macrophages and scattered lymphocytes were observed. No fibrosis was observed between the implants and the bone. Moreover, the material was osteoconductive acting as a "scaffold" for bone cells, and there was a progressive increase in bone growth in and around the implants. CONCLUSION: This new porcine biomaterial-collagen paste seemed to be biocompatible, bioresorbable, and osteoconductive.

Topical application of melatonin and growth hormone accelerates bone healing around dental implants in dogs.

BACKGROUND: Growth hormone (GH) and melatonin belong to the group of growth factors. These substances have been proposed to improve and accelerate osseous healing using topical applications. PURPOSE: The aim of this study was to evaluate the effect of the topical administration of GH and melatonin on osseointegration of dental implants in Beagle dogs 2, 5, and 8 weeks after their insertion. MATERIALS AND METHODS: Twelve adult Beagle dogs and 48 implants were used in the study. The maxillary and mandibular premolars and molars were extracted. Each mandible received cylindrical screw implants of 3.25 mm in diameter and 10 mm in length. Prior to implanting, 4 IU of recombinant human GH and 1.2 mg of lyophilized powdered melatonin was applied to one osteotomy at each side of the mandible. None was applied at the control sites. The implants were retrieved at 2, 5, and 8 weeks for light microscopic examination, energy-dispersive x-ray microanalysis, and histomorphometric measurements in ground sections. RESULTS: At week 2, BIC was significantly higher in the melatonin-growth hormone group than in the implant control one (34.20 vs 25.05%; p = .010). The M-GH group also increased significantly the peri-implant bone area (64.72 vs 53.20%; p = .038) and interthread bone area (35.62 vs 25.08%; p = .02). At weeks 5 and 8, BIC and bone density around implants were similar to both groups. Significant differences were detected in bone neoformation at 8 weeks in ML-GH group (9.04 vs 7.53%; p = .05). Regarding the mineral composition, in ML-GH group increments in concentrations of phosphorus (10.70 vs 10.34; p = .013) were observed at 2 weeks and of magnesium (0.29 vs 0.25; p = .019) 5 weeks after implantation. CONCLUSION: The present study confirms that GH and melatonin synergistically enhance new bone formation around titanium implants in early stages of healing.

Peri-implant bone reactions to immediate implants placed at different levels in relation to crestal bone. Part II: a pilot study in dogs.

PURPOSE: The aim of the present study was to evaluate bone-to-implant contact (BIC) and bone remodeling dynamics after immediate implant placement at different levels in relation to the crestal bone with two different implant designs in beagle dogs. MATERIALS AND METHODS: The mandibular second, third and fourth premolars of six beagle dogs were extracted bilaterally and three implants were immediately placed in the hemi-arches of each dog. Randomly, three cylindrical and three tapered implants were inserted crestally (control group) or 2 mm subcrestally (test group). Both groups were treated with a minimal mucoperiosteal flap elevation approach. A gap from the buccal cortical wall to the implant was always left. Three dogs were allowed a 4-week submerged healing period and the other three an 8-week submerged healing period. The animals were sacrificed and samples were obtained. Biopsies were processed for ground sectioning. Histomorphometric analysis was carried out in order to compare BIC, de novo bone formation and bone remodeling. RESULTS: All implants osseointegrated clinically and histologically. Healing patterns examined microscopically at 4 and 8 weeks for both groups (crestal and subcrestal) yielded similar qualitative bone findings. The total BIC mean value for the crestal group was 36.48 ± 3.4% and for the subcrestal group was 41.46 ± 4.2%. The mean percentage of newly formed BIC was greater with the cylindrical implant design (46.06 ± 1.09%) than with the tapered design (33.89 ± 1.72%). There was less bone resorption in the subcrestal group (test) than crestal group (control). CONCLUSION: These findings suggest that apical positioning of the top of the implant does not jeopardize bone crest and peri-implant tissue remodeling. However, less resorption of the lingual crest may be expected when implants are placed 2 mm subcrestally. Moreover, higher BIC values were found in cylindrical implants placed subcrestally.

Evaluation of periimplant bone neoformation using different scanning electron microscope methods for measuring BIC. A dog study.

OBJECTIVES: [corrected] The aim of this study was to determine which of three methods for measuring BIC (bone-to-implant contact), using vestibular and lingual scanning electron microscopy (SEM) for different implant systems at 15, 30 and 90 days post-surgery was the most precise. An elemental analysis with SEM was used to evaluate neoformed bone composition for three implant systems at the same study times. MATERIAL AND METHODS: 36 implants were placed in eighteen Beagle dogs mandible about one year old and weighing approximately 12-13 kg in order to evaluate bone apposition to three different implant surfaces. It was used the third and fourth premolar and first molar distal sockets in both quadrants of the mandible (3P3, 4P4 and 1M1). Teeth were hemi-sected and the distal roots were removed. The specimens were prepared for histological examination and each section surface was stained using Masson's trichrome and hematoxylin and eosin stains. BIC evaluations were performed by the three methods, BIC I (the quantity of mineralized bone in direct contact with the implant's titanium surface across the entire threaded area); BIC II (along a line that passes from apex to apex of the implant threads); BIC III (both in areas around and above the threads and in between threads). RESULTS: Both BIC and bone content were analyzed for all implants placed in P3, P4 y M1 alveoli on both, the buccal and palatine sides (elemental analysis quantified Ca, P, O and C). It was seen it was only at the ninety-day mark that high percentages of calcium were present. CONCLUSIONS: This study suggest that BIC III evaluation is the most certain method for establishing the quantity of bone formed as the BIC area. Key words:Bone-to-impant contact, dogs, extraction socket, implants.

Frecuencia de los factores de riesgo de Cáncer Cervicouterino en mujeres de 14-65 años, Comunidad Ramadas, Provincia Tapacarí-Cochabamba gestión 2012 / Frequency of risk factors for Cervical Cancer in women aged 14-65 years, Community Ramadas, Tapacarí-Cochabamba Province Management 2012

El cáncer cervicouterino se puede detectar a través de frotis de Papanicolaou, la causa generalmente es la infección por el virus del papiloma humano. El presente estudio busca identificar la frecuencia de los factores de riesgo de cáncer de cuello uterino en mujeres de 14-65 años en la comunidad de Ramadas. Se realizó un muestreo no probabilístico de tipo discrecional, seguridad del 85%; precisión del 3%(0,03); proporción esperada 5%, proporción el valor p=0,5(50%). También se realizó una revisión de los resultados de toma PAP, haciendo un total 218 muestras citológicas. Los resultados mostraron que el: microorganismo más frecuente son cocos bacilos cortos; Indice de Masa Corporal( IMC) saludable (63%) ; indican tener una sola muestra de PAP (32%), nunca se realizó una muestra de PAP (25%); asintomaticas de ITS (71 %) ; de factor económico regular (77,3%); mujeres gran multiparas (34%), no saben si tienen antecedente familiar de cáncer uterino (85%); no utiliza ningún método anticonceptivo (70%) y solo toman la pildora anticonceptiva (2%), indican que no consume cigarrillo y en el mismo porcentaje indican que no presentan múltiples parejas sexuales (99%), tienen su primer embarazo a los 18-22 años de edad (32%). La cobertura de toma de PAP es 21 % en la gestión 2011. Por lo tanto se deduce que los factores de riesgos de cáncer cervicouterino antes descritos, son similares a los descritos en la literatura médica.

Cervical cancer can be detected by Papanicolaou smear the general cause is a Human papilloma virus infection. This study seeks to identify frequency of the cervical cancer risk factors in woman aged 14 to 65 years old on Ramadas community. A non probabilistic optional sampling was held, with a 85% of security, 3% (0.03) accuracy, with a expected proportion of 5 % value proportion p= 0,5(50%). A results review from the PAP sampling was held whit a total of 218 cytological samples. Results show that:The most frequent microorganisms are short bacilli cocci; Healthy body mass index (BMI) (63%); have indicated only one PAP sample (32%), never performed a PAP (25%); non STI symptomatic (71%), regular economic factors (77.3%); grand multipary (34%), without knowledge of familiar antecedents of cervix cancer (85%), non contraceptive method use (70%), just taking contraceptive pills (2%), non smoking as non multiple sexual partners indicated (99%), first pregnancy at 18 to 22 years old (32%). PAP smears coverage at 2011 gestion is 21%.

Crestal bone loss evaluation in osseotite expanded platform implants: a 5-year study.

OBJECTIVE: The aim of this prospective clinical study was to evaluate the survival rates at 5 years of expanded platform implants placed in the anterior zone of the maxilla and immediately restored with single crowns. MATERIALS AND METHODS: Implants incorporating the platform-switching concept were placed in fresh extraction sockets in the maxillary arch, with each patient receiving a provisional restoration immediately after implant placement. After 15 days, final screwed restorations were inserted. Mesial and distal bone heights were evaluated using digital radiography on the day following implant placement and at 1, 3, 6, 9, 12, 24, 36 months and 5 years. Primary stability was measured with resonance frequency analysis (RFA) using the Osstell Mentor device. Sixty-four implants were placed in 32 men and 32 women ranging in age between 29 and 60 (mean: 39.64 ± 5.16 years). RESULTS: Mean mesial bone loss was 0.08 mm (SD 0.42). Mean distal bone loss was 0.14 mm (SD 0.56). Over the course of the 5 years, the mean RFA value was 72.5 ± 3.1 SD. CONCLUSION: The platform-switched implants remained stable over the course of 5 years and had an overall survival rate of 97.1%.

Experimental model of bone response to xenografts of bovine origin (Endobon): a radiological and histomorphometric study.

OBJECTIVE: To carry out a radiological and histomorphometric evaluation of bone response to bovine bone implants inserted in rabbits' tibiae. MATERIALS AND METHODS: Twenty New Zealand rabbits weighing 3900-4500 g were used. Twenty bovine bone implants (Endobon) in granulated form of 500-1000 µm granulometry were inserted in the proximal metaphyseal area of the animals' right tibia and 20 control areas were located in the proximal metaphyseal area. Following implantation, the animals were sacrificed in four groups of five, after 1 month, 2 months, 3 months and 4 months, respectively. Anteroposterior and lateral radiographs were taken. Samples were sectioned at 5 µm and stained using Hematoxylin-Eosin and Masson's trichromic. RESULTS: After 4 months, radiological images showed complete repair of the bone defects. No healed or residual bone alterations attributable to the presence of the implant were observed. Histomorphometric analysis at 4 months showed the presence of a higher density of newly formed bone with mean values for new bone, residual graft material and non-mineralized connective tissue of 22.8 ± 1.5%, 39.4 ± 2.3% and 37.7 ± 2.5%. There were no statistically significant differences in the length of cortical formation with bovine bone, 98.8 ± 1.1%, compared with the control group, 99.1 ± 0.7%, at the end of the study period. CONCLUSIONS: The biomaterial used in the study was shown to be biocompatible, osteoconductive and non-resorbable and as such a possible bone substitute that does not interfere with normal reparative bone processes.

Evaluation of effects of topic melatonin on implant surface at 5 and 8 weeks in Beagle dogs.

PURPOSE: The aim of this study was to evaluate the effect of the topical application of melatonin on osteointegration of dental implants in Beagle dogs 5 and 8 weeks after their insertion. MATERIALS AND METHODS: For subsequent insertion of dental implants, upper and lower premolars and molars were extracted from 12 Beagle dogs. Each mandible received cylindrical screw implants of 3.25 mm in diameter and 10 mm in length. The implants were randomly assigned to the mesial and distal sites on each side of the mandible. Prior to implanting, 1.2 mg lyophylized powder melatonin was applied to one bone hole at each side of the mandible. None was applied at the control sites. Eight histological sections per implant were obtained for histomorphometric studies. RESULTS: After 5- and 8-week treatment periods, melatonin significantly increased the inter-thread bone (p < 0.05) and new bone formation (p < 0.05) in comparison to control implants in both weeks. There were no significant increases in the bone-to-implant contact and peri-implant bone (p > 0.05). CONCLUSION: Topical application of melatonin may act as a biomimetic agent in the placement of endo-osseous dental implants at 5 and 8 weeks after the implantation.